Pixium Vision makes a start with Prima


One year after the Prima device was implanted, all five patients in the Paris-based Prima-FS trial
had light perception in the central retinal area, none had had central
visual activity at enrollment, meeting the study’s primary endpoint.
Most of the patients could identify letters, and some sequences of
letters.

Read more »

2019-09-11T17:29:55+02:00July 18th, 2019|News|
Go to Top